The effect of primary urological cancers on survival in men with secondary prostate cancer
Authors:
- Mike WenzelMWMike Wenzel
- Christoph WürnschimmelCWChristoph Würnschimmel
- Luigi NoceraLNLuigi Nocera
- Claudia Collà RuvoloCRClaudia Collà Ruvolo
- Zhe TianZhe Tian
- Fred SaadFSFred Saad
- Alberto BrigantiABAlberto Briganti
- Derya TilkiDTDerya Tilki
- Markus GraefenMGMarkus Graefen
- Philipp MandelPMPhilipp Mandel
- Felix K.H. ChunFCFelix K.H. Chun
Open Access
- 16 August 2021
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 81 (15) , 1149-1158
Abstract
Background: To test the effect of urological primary cancers (bladder, kidney, testis, upper tract, penile, urethral) on overall mortality (OM) after secondary prostate cancer (PCa).Methods: Within the Surveillance, Epidemiology and End Results (SEER) database, patients with urological primary cancers and concomitant secondary PCa (diagnosed 2004‐2016) were identified and were matched in 1:4 fashion with primary PCa controls. OM was compared between secondary and primary PCa patients and stratified according to primary urological cancer type, as well as to time interval between primary urological cancer versus secondary PCa diagnoses.Results: We identified 5,987 patients with primary urological and secondary PCa (bladder, n = 3,287; kidney, n = 2,127; testis, n = 391; upper tract, n = 125; penile, n = 47; urethral, n = 10) versus 531,732 primary PCa patients. Except for small proportions of Gleason grade group and age at diagnosis, PCa characteristics between secondary and primary PCa were comparable. Conversely, proportions of secondary PCa patients which received radical prostatectomy were smaller (29.0 vs. 33.5%), while no local treatment rates were higher (34.2 vs. 26.3%). After 1:4 matching, secondary PCa patients exhibited worse OM than primary PCa patients, except for primary testis cancer. Here, no OM differences were recorded. Finally, subgroup analyses showed that the survival disadvantage of secondary PCa patients decreased with longer time interval since primary cancer diagnosis.Conclusions: After detailed matching for PCa characteristics, secondary PCa patients exhibit worse survival, except for testis cancer patients. The survival disadvantage is attenuated, when secondary PCa diagnosis is made after longer time interval, since primary urological cancer diagnosis.Keywords
This publication has 27 references indexed in Scilit:
- Incidence of Second Primary Malignancies in Patients with Neuroendocrine TumoursNeuroendocrinology, 2015
- Second malignancies in long-term testicular cancer survivorsInternational Urology and Nephrology, 2013
- The risk of bladder cancer in patients diagnosed with other primary neoplasms: Analysis of the SEER databaseUrologic Oncology: Seminars and Original Investigations, 2013
- Risk of prostate cancer among cancer survivors in the NetherlandsCancer Epidemiology, 2013
- Primary cancers before and after prostate cancer diagnosisCancer, 2012
- Epidemiology of Multiple Primary Cancers2009
- Endogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective StudiesJNCI: Journal of the National Cancer Institute, 2008
- Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular CancerJNCI: Journal of the National Cancer Institute, 1997
- Multiple Primary Malignant Neoplasms Associated with Prostate Cancer in 312 Consecutive CasesUrologia Internationalis, 1997
- Incidence of second primary cancer following testicular cancerEuropean Journal of Cancer, 1993